Trials / Completed
CompletedNCT00000244
Effects of Dynorphin 1-13 on Heroin Addiction - 1
Effects of Dynorphin 1-13 on Heroin Addiction
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effects of IV dynorphin in humans during acute heroin abstinence, in order to determine that dynorphin suppresses acute opiate withdrawal, reduces opiate craving, and is safe at doses required to produce the above effects.
Detailed description
Randomized double blinded study of the effects of a single IV dose of dynorphin A 1-13 on heroin withdrawal in human opiate addicts
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dynorphin 1 - 13 |
Timeline
- Start date
- 1994-08-01
- Primary completion
- 1997-03-01
- Completion
- 1997-03-01
- First posted
- 1999-09-21
- Last updated
- 2015-05-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000244. Inclusion in this directory is not an endorsement.